Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-018816
Filing Date
2013-03-26
Accepted
2013-03-26 16:04:30
Documents
1
Period of Report
2013-03-25

Document Format Files

Seq Description Document Type Size
1 rrd375079.html 3  
1 rrd375079.xml 3 2153
  Complete submission text file 0001181431-13-018816.txt   3693
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
HUSSEY JAMES M (Reporting) CIK: 0001230480 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35144 | Film No.: 13716918

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations